The DOI matches its Crossref record; 255 of the 260 references it cites were found in a registry or an index.
Lipid nanoparticle-mediated drug delivery to the brain
Abstract
Lipid nanoparticles (LNPs) have revolutionized the field of drug delivery through their applications in siRNA delivery to the liver (Onpattro) and their use in the Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines. While LNPs have been extensively studied for the delivery of RNA drugs to muscle and liver targets, their potential to deliver drugs to challenging tissue targets such as the brain remains underexplored. Multiple brain disorders currently lack safe and effective therapies and therefore repurposing LNPs could potentially be a game changer for improving drug delivery to cellular targets both at and across the blood-brain barrier (BBB). In this review, we will discuss (1) the rationale and factors involved in optimizing LNPs for brain delivery, (2) ionic liquid-coated LNPs as a potential approach for increasing LNP accumulation in the brain tissue and (3) considerations, open questions and potential opportunities in the development of LNPs for delivery to the brain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“delivering LNPs across the blood–brain barrier (BBB) after systemic administration remains underexplored.”
From Predictive High-Throughput Platform for Dual Screening of mRNA Lipid Nanoparticle Blood–Brain Barrier Transfection and Crossing (2024) · cites this paper as [27]
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Lipid nanoparticles for mRNA delivery
Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Daneman, R., & Prat, A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020412 · Cited by 3,437
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047
Research works printed but not linked: 8
- Sweeney, 2018, Blood-brain barrier: from physiology to disease and back, Physiol. Rev.
- Kulkarni, 2018, On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA, ACS Nano, 12
- Carrasco, 2021, Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration, Commun. Biol., 4
- E.K. Bin Shi, Andrea Matter, Karen Leander, Stephanie Young, Ed Carlini, Alan B. Sachs, Weikang Tao, Marc Abrams, Bonnie Howell, and Laura Sepp-Lorenzino, Biodistribution of Small Interfering RNA at the Organ and Cellular Levels after Lipid Nanoparticle-mediated Delivery, J. Histochem. Cytochem. 59 (2011) 727–740. · DOI · Paper page
- Zhang, 2019, Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma, Proc. Natl. Acad. Sci. U S A, 116, 23714, 10.1073/pnas.1906346116 · DOI
- R. Carter, The human brain book: An illustrated guide to its structure, function, and disorders. Penguin, 2019.
- He, 2020, Brain microvascular endothelial cell derived exosomes potently ameliorate cognitive dysfunction by enhancing the clearance of Aβ through Up-regulation of P-gp in mouse model of AD, Neurochem. Res., 45
- Khare, 2022, Lipidoid nanoparticles increase ATP uptake into hypoxic brain endothelial cells, Eur. J. Pharm. Biopharm., 180, 238, 10.1016/j.ejpb.2022.10.011 · DOI
Cited by
Sorted by citations
Items 101–187 of 187
Ghosh, S., Fan, Y., Laufer, B. I., Stephenson, W., Zang, N., Lawrence, J., Lin, H. H., Sen, S., Miller, S. E., Chu, S., et al. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100303 · Cited by 3
Novel insights into non-coding RNAs and their role in hydrocephalus
Cui, Z., He, J., Li, A., Wang, J., Yang, Y., Wang, K., Liu, Z., Ouyang, Q., Su, Z., Hu, P., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00963 · Cited by 3
Lu, H., Zhang, W., Wu, Z., Peng, Y., Liu, F., Gao, S., & Deng, L. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126546 · Cited by 3
Non-viral delivery of genome-editing tools for treatment of genetic disorders
Yang, J., Chen, Y., Chen, X., & Ping, Y. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.02.014 · Cited by 3
Stage-adaptive nanotherapeutic design for blood–brain barrier navigation in ischemic stroke
Li, T., Zhou, Y. Q., Chen, Y., & Zou, L. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127020 · Cited by 3
Alzheimer's Disease and Polymeric Nanocarriers: Synergistic Advances in Targeted Drug Delivery
Kumar, L., Rana, R., Shaikh, N. K., Thakur, A., Kashyap, S., Aggarwal, V., & Jyothiraditya, V. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266347890250409153450 · Cited by 3
Duan, Y.-Z., Yao, T.-T., Shao, Y., Liu, L., Zhou, H., & Cheng, Y. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13207-9 · Cited by 4
Material considerations for delivering therapeutics across the blood–brain barrier
Zoba, A. N., & Tringides, C. M. (2025) · APL Materials · doi:10.1063/5.0284305 · Cited by 2
Li, S., Wang, A., Zhang, R., Zhang, M., Guo, P., Chen, B., Yuan, Y., Wang, H., & Wang, J. (2025) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2025.101089 · Cited by 2
Nakashima, K. T., Wang, S., & Castle, M. J. (2025) · Brain Sciences · doi:10.3390/brainsci15101058 · Cited by 2
Music enhances lipid nanoparticle brain delivery and mRNA transfection in brain cells
Mora‐Raimundo, P., Gilon, A., Kadosh, H., Richtman, Y., Sela, M., Ackerman, S., Chen, G., Abel, R., Kagan, S., Sharf‐Pauker, N., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114301 · Cited by 3
Engineered RNA Devices for In Vivo Targeted Therapeutics via Advanced Delivery Systems
Luo, W., Liu, X., Han, Y., Duan, Y., Yu, C., Kong, N., & Xie, T. (2025) · Aggregate · doi:10.1002/agt2.70191 · Cited by 2
Zhao, E., Yu, Y., Gao, Y., Li, T., Hao, S., Chen, M., Xu, M. J., Sinkemani, A., Yang, C., Yin, Y., et al. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00308-0 · Cited by 2
Assaf, S. M., Almnayyes, A. I., Obaidat, R., & Maaroof, K. T. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107803 · Cited by 2
Feng, Y., Zhao, Y., Han, J., Li, F., Li, G., Wang, B., Chen, Q., & Song, J. (2026) · Nano Research · doi:10.26599/nr.2026.94908571 · Cited by 3
A review on cellular ferroptosis in traumatic brain injury: Mechanisms and therapeutic implications
Qiang, J.-L., Ren, M.-M., Yuan, Y.-S., Yang, X., Quan, X., Zhu, R.-T., Zhang, M., & Zhu, J. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115736 · Cited by 2
Recent Advances in the Non-viral Delivery of Genes to Central Nervous System Disorders
Marei, H. E. S. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01703-z · Cited by 3
Targeted Protein Degradation and Delivery Strategies in the Context of Neurological Disorders
Lu, H., Yang, Z., Kayumov, M., Wang, Y., Tang, F., Wang, X., Xia, T., Lei, T., Tong, F., & Gao, H. (2026) · ACS Nano · doi:10.1021/acsnano.6c04420 · Cited by 3
Wen, M., Li, J., Xu, S., Li, W., Wang, S., Guo, Z., Chen, J., & He, L. (2026) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2026.05.019 · Cited by 2
The changing landscape of gene editing tool delivery in neurological disorders
Chen, Y., Paul, A., Collins, M. G., & Lee, H. Y. (2023) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2023.100509 · Cited by 2
Delivery Systems in Neuronal Direct Cell Reprogramming
Redi, G., Piano, F. D., Cappellini, S., Paladino, M., den Breejen, A., Fens, M. H. A. M., & Caiazzo, M. (2025) · Cellular Reprogramming · doi:10.1089/cell.2025.0008 · Cited by 2
Huang, J., Chen, H.-W., Huang, C., Lin, R. J., Gao, Y., Wu, J., Xu, Y., & Su, Z. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c02314 · Cited by 2
Mishra, M. K., & Chahal, D. P. (2023) · MIGRATION LETTERS · doi:10.59670/ml.v20is13.6291 · Cited by 1
Gene editing for HD: Therapeutic prospects
Chen, R. Z., & Vogt, T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95672-7.00021-2 · Cited by 2
Lipid nanoparticles in medicine: advances in diagnostics, therapeutics, and future directions
Tran, V. A., Vo, T. T. T., Thanh, N. C., Tran, T. D., & Tran, T. N. A. (2025) · Nano Futures · doi:10.1088/2399-1984/ada900 · Cited by 1
Volloch, V., & Rits‐Volloch, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094252 · Cited by 3
Li, J., Tong, S., Yi, H., Liu, R., Hu, W., Tao, S., Huang, H., & Wu, J. (2025) · Journal of Cluster Science · doi:10.1007/s10876-025-02832-z · Cited by 1
He, Z., Liu, J., Jin, Q., Ren, S., Liu, L., & Liu, Y. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1588598 · Cited by 1
Evaluating cell cycle- and autophagy-associated cellular accumulation of lipid-based nanoparticles
Wang, Y., Luo, G., Wang, H., Zheng, Y., Xu, X., Zhou, W., Lin, J. Z., Chen, B. Y., Guo, Y., Jin, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60962-4 · Cited by 1
Strategies of designing lymph nodes-targeting nanoparticles for cancer immunotherapy
Huang, Z., Fu, F., Deng, C., Wu, S., Huang, M., Sha, X., Wei, M. Q., Zhang, Z., & Zhang, Y. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111993 · Cited by 2
Harada, A., Tanaka, R., Otake, H., Yoshimura, M., Wada, T., Nagahama, T., & Nagai, N. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17121519 · Cited by 2
Wilk, A., Lakomy, K. W., Setkowicz, Z., Szary, K., Stachura, R., Marzec, K. M., Rugiel, M. M., & Chwiej, J. G. (2025) · Scientific Reports · doi:10.1038/s41598-025-29434-z · Cited by 1
Dang, Y. N., Shen, F. N., Wang, S. N., Zhang, Y. N., Lu, X. N., Qin, D. N., Feng, D., Song, Y. N., Cheng, Z., Ma, R. N., et al. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin45212 · Cited by 1
Liposome-mediated simvastatin in vaccine adjuvants: Its application and mechanism
Chen, Z., Xia, Z., Chen, L., Nie, Q., Gong, W., Cao, W., Wang, X., Zou, Y., Zhang, S., Yang, Y., et al. (2026) · Molecular Immunology · doi:10.1016/j.molimm.2026.01.002 · Cited by 1
Gu, L., Liu, J., Wang, C., Shan, X., Li, S., Zhang, X., Xia, L., & Li, J. (2026) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2026.100503 · Cited by 3
Ding, C., Zhang, B., Li, K., Wang, Q., Zhang, X., Ma, X., He, Q., Li, Z., Xin, H., Meng, X., et al. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2026.217743 · Cited by 1
Brain delivery of lipid nanoparticles with shuttle peptides
Martínez-Martínez, N., CARRERA-RODRÍGUEZ, L., Vargas, R., Hernández-Munaín, C., Suñé-Pou, M., & Suñé, C. M. I. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.02.005 · Cited by 1
Shen, K. C., Li, X., Wang, H., Zhang, H., Yuan, Z., Zheng, X. F., He, L., & Chen, T. (2026) · Advanced Functional Materials · doi:10.1002/adfm.74986 · Cited by 1
Li, Y., Xu, X., Hao, T., Mao, X., Guo, P., Zhu, X., Jin, W. J., Geng, H., Li, F., Hu, X., et al. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.2167334 · Cited by 1
Norimatsu, J., Mizuno, H. L., Mochida, Y., Fukushima, S., Uchida, S., Cabral, H., & Anraku, Y. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01925 · Cited by 1
Mechanisms of transport across the blood–brain barrier
Das, N. G., & Das, S. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33623-2.00019-2 · Cited by 1
Phullay, P., Panwar, R., Bajwa, S., Wadhwa, K., Chauhan, P., Pahwa, R., Kriplani, P., Rajak, H., Awasthi, R., & Dureja, H. (2026) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-026-00616-z · Cited by 1
The future of pediatric gene therapy: CRISPR-Cas9, AI, and personalized medicine
Pan, Y., Ding, J., Wang, W., Xu, D., Fan, J., & Zhang, W. (2026) · Pediatric Research · doi:10.1038/s41390-026-05270-3 · Cited by 2
Liu, Y., Guo, X., Hu, Q., Gan, C., Nie, S., Xiang, J., Liu, Y., Zou, J., Wu, X., Li, C., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103568 · Cited by 3
Ge, X., Wekselblatt, J. B., Elmore, S. T., Wang, B., Wang, T., Dai, R., Zhang, T., Dave, H., Ghaderi, M., Anilkumar, A. R., et al. (2025) · Advanced Science · doi:10.1002/advs.202501033 · Cited by 1
Opportunities and Challenges of Biomaterials in Brain Disease
Zheng, W., Jiang, M., Dong, N., Fang, H., Tian, H., & Chen, X. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500746 · Cited by 2
Freire, J., Pang, S., McGee, J. E., Heinrich, M. J., Xie, J., Hammarlund, E., Shaw, D. C., Zhou, Y., Wang, Y., Porter, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.30.685635 · Cited by 1
Курмазов, Н. С., Chervonetskiy, S., Александровна, П. В., Sysoev, Y. I., & Оковитый, С. В. (2023) · Drug development & registration · doi:10.33380/2305-2066-2023-12-4-1642
Wang, Y., Luo, G., Wang, H., Zheng, Y., Xu, X., Zhou, W., Lin, J. Z., Chen, B. Y., Jin, Y., & Sui, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.19.579560
Emerging Voices in Drug Delivery – Breaking Barriers (Issue 1)
Nguyen, J., & Owen, S. C. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115273
Neuroengineering: History, modeling, and deliverables
Lucot, K. L., Napoliello, R. E., Vij, P. A., & Fink, K. D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95730-4.00007-x
Effects of valproic acid on rat C6 glioma cells proliferation and animals survival in the experiment
Panteleichuk, A. B., Savosko, S. I., Shmeleva, A., Petriv, T. I., Ивановна, К. А., Grabovyi, O. M., & Eg, P. (2025) · Ukrainian Neurosurgical Journal · doi:10.25305/unj.311770
New Transferrin Receptor‐Targeting Conjugate Effectively Delivers DNA to Mouse Brain
Song, M.-S., Bustos, A. H., Bastue, L. B., Mikutavicius, J., Swiderski, P. M., Clemens, K. J., Habib, N., Rossi, J. J., & Astakhova, K. (2025) · Angewandte Chemie · doi:10.1002/ange.202500247
Rachamala, H. K., Nakka, N. M. R., & Marepally, S. K. (2025) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2025056257
Nanomaterials in Alzheimer’s Disease Treatment and Environmental Impression
Chandra, P., Sharma, H., Sachan, N., & Gautam, M. K. (2025) · Current Materials Science · doi:10.2174/0126661454386874250711102028
Development of siRNA therapeutics to combat microbial infections: a bibliometric analysis
He, Y., Yuan, Y., Zhou, M., Li, M., Li, L., Li, C., Liang, X., Liu, P., Wang, W., & Deng, Z. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1697880
Mineralized Tissue-Targeting Expression System for Local Control of Gene ExpressionPreprint
Liu, J., Chen, Q., Yoon, I., Makkar, H., Zhang, S., Chen, Y., Li, Y., Thussananutiyakul, J., Xue, L., Zhang, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.25.690451
Engineering Liposomes for Neurodegenerative Diseases: Targeted Delivery and Regenerative Potential
Ashirov, O. N., Azimova, S. S., Angelov, B., & Angelova, A. (2025) · ChemNanoMat · doi:10.1002/cnma.202500258 · Cited by 2
Ferrocene-contained cationic lipids via Ugi reaction for gene delivery and tumor cell ferroptosis
Wang, R., Tian, X., Li, J., Chen, J., Hu, Y., & Zhang, J. (2026) · Journal of Materials Science · doi:10.1007/s10853-026-12175-3
Layers of Hope: How Graphene and Nanostructures Hold Promise for Cancer Therapy
Ribeiro, B. F. M., & Machado‐Santelli, G. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052336
A comprehensive review on solid lipid nanoparticles as a new frontier for treatment of migraine
Waqar, M. A., Fatima, F., Rehman, M. N., Khalid, M., Ashraf, A., Babar, J., Saqib, K., & Saleem, M. (2026) · International Journal of Polymeric Materials · doi:10.1080/00914037.2026.2626712
Zhang, Y.-J., Huang, Y., Lu, Z., & Yuan, Z. (2026) · ACS Materials Au · doi:10.1021/acsmaterialsau.6c00024
Li, Y., Xu, X., Hao, T., Mao, X., Guo, P., Zhu, X., Jin, W. J., Geng, H., Li, F., Hu, X., et al. (2026) · Angewandte Chemie · doi:10.1002/ange.2167334
Xu, J.-J., Xu, T., Gan, L., Deng, S., Lian, Q., Ye, J., Guo, Y., Li, H., Geng, Y., Yao, H., et al. (2026) · Glia · doi:10.1002/glia.70159
Targeting the NAD+–PARP1–XRCC1 axis in ALS
Ibrahim, M., Hossain, D. M. N., Ooi, L., Hasan, M. M., Ahsan, S., Salem, A. K., Piazza, G. A., Feng, X., & Ahsan, F. (2026) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2026.04.004
Moëlo, C., Kronqvist, N., & Johansson, J. (2026) · Advanced Biology · doi:10.1002/adbi.202500721
Physicochemical characterization of ionic liquid incorporated into diblock copolymeric nanoparticles
Edgecomb, S. X., Ontiveros, A. I., Vashisth, P., Parker, M. V., Hamric, A., Cochran, M. O., Chism, C. M., & Tanner, E. E. L. (2026) · Journal of Ionic Liquids · doi:10.1016/j.jil.2026.100211
Self-citationChen, J., Xing, T., Song, J., Zhang, H., Fu, S., Jiang, L., Xu, Y., He, L., Liu, H., Ma, H., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.177805
Yusuf, A., Harati, R., Greish, K., & Haider, M. A. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108594
Willems, R., Cappelletti, M., Schüre, J., Deichmann, R., Hattingen, E., & Arendt, C. T. (2026) · Scientific Reports · doi:10.1038/s41598-026-56181-6
Zeng, Y., Song, T., Liu, S., Liao, X., Hu, M., Yang, H., He, S., & Song, X. (2026) · Chinese Medical Journal BioMed · doi:10.65457/cmjbm-2026-0005
Introduction to Drug Delivery Systems: Historical perspectives and current trends
Borkar, S., Wagh, B., Kadale, P., Mahale, N., Bhagwat, A. A., Doke, R. R., & Vinchurkar, K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40620-1.00001-7
Applications of biomimetic nano-delivery systems in the treatment of brain disorders
Yin, M., Mi, J., Jiang, X., Su, X., Tong, Y., & Zhu, Y. (2026) · Chinese Chemical Letters · doi:10.1016/j.cclet.2026.113150
Beyond Carrier Design: Fabrication Method as the Hidden Driver of NSAID Nanomedicine Performance
Pauna, A.-M. R., Mititelu-Tarțău, L., Koush, A. A., Vasluianu, R.-I., Ashkar, J. A., Stan, R. T., Radu, V., Moraru, M. C., Popa, C. G., Gavril, R. F., et al. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18070877
Choudhury, K. K., Sharafudheen, R. A., Kajol, & Pathak, R. (2026) · Macromolecular Bioscience · doi:10.1002/mabi.70216
Tian, Z., Wang, X., Benitez, A. P., Guerrero, E. D., Duan, Y., Wei, J., Farbiak, L., & Siegwart, D. J. (2026) · Advanced Materials · doi:10.1002/adma.74762 · Cited by 1
Mitophagy in neuronal health and disease: from mechanisms to neurodegeneration
Basak, B., Riley, J. F., Nataraj, N. M., & Holzbaur, E. L. F. (2026) · Journal of Clinical Investigation · doi:10.1172/jci199847 · Cited by 1
Wang, L., Yuan, H., Mou, Y., Zhang, K., Zhou, T., & Huang, X. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115347
Wang, X., Sun, Y., Jin, H., Zhou, H., Yang, Y., Su, Y., Wang, J., Zhao, Z., Yu, W., Wu, M., et al. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e01078
Hybrid lipid-nanogels: nanolipogels for mRNA delivery
Oudkerk-Sodia, E., Xu, R., Chu, R., Dabas, R., Patri, S., Tidd, C., Blagojevic, L., Woscholski, R., & Kamaly, N. (2026) · RSC Advances · doi:10.1039/d6ra07548g
Wei, B., Wu, Y., Zhou, J., Li, L., Jin, L., Liu, W., Jin, F., Li, R., Guo, S., Yang, Z., et al. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6c13505
Huang, Q., Zuo, Y., Xie, Y., Liu, Z., Wang, L., Xu, H., Yu, M., & Liu, C. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6c01137
Chemically tailored lipids mediate solid-phase RNA programming of mineralized microenvironments
Liu, J., Chen, Q., Thussananutiyakul, J., Yoon, I., Makkar, H., Zhang, S., Chen, Y., Li, Y., Xu, J., Xue, L., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124680
Ionizable Lipid Nanoparticles as a siRNA Delivery Carrier: A Review
Prajapat, V., Sharma, G., Dhania, N. K., & Maparu, A. K. (2026) · ACS Applied Nano Materials · doi:10.1021/acsanm.6c03278
王静艳, Zeng, X., Niu, P., Shi, J., & Yu, W. (2026) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.70081
Synthesis of deuterated ALC-0315 for contrast variation SANS analysis of lipid nanoparticles
Zhang, H., Leite, W. C., Pingali, S. V., Nusser, B. D., Urban, V. S., & O’Neill, H. (2026) · RSC Advances · doi:10.1039/d6ra04368b
From bench to clinic, are organoids ready for modeling drug delivery in brain disease?
Xiang, Q., Zheng, M.-X., Yuan, J.-R., Lin, S.-R., Li, X., & Li, X.-H. (2026) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2026.100693
Metadata
- Authors
- Khare, P., Edgecomb, S. X., Hamadani, C. M., Tanner, E. E. L., & S Manickam, D.
- Affiliations
- Duquesne University (US)
- University of Mississippi (US)
- Corresponding author
- Tanner, Eden E.L.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2023-06
- Volume
- 197
- Pages
- 114861
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W4372198073
- Cited by
- 187
- References
- 260
- Citations by year
- 2026: 52 · 2025: 82 · 2024: 40 · 2023: 13
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Advanced Drug Delivery Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Duquesne University
- Office of Research, University of Kansas
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- lipid nanoparticles, brain drug delivery, blood-brain barrier, ionic liquid coating
- MeSH terms
- COVID-19, Brain, Humans, Lipids, Liposomes, RNA, Small Interfering, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review